Patent Law Weblog
recent posts
- USPTO Moves to Protect Design Rights for Digital Innovations
- Judicial Conduct and Disability Committee Has Its Say, Denies Judge Newman’s Latest Request for Review
- PTAB Issues Judgment on Priority in CRISPR Interference
- Parties File Supplemental Priority Statements in CRISPR Interference
- Why the Alice Test is Stupid, Part V: The Goalposts Keep Moving
about
Month: June 2009
-
By Donald Zuhn — Last Thursday, the White House announced that President Obama had selected David Kappos (at right), the Vice President and Assistant General Counsel of Intellectual Property Law at IBM, to head up the U.S. Patent and Trademark Office. In the days since that announcement, a number of patent organizations and trade…
-
By Bradley Crawford — In the first post in this series, background information from Mr. Enrique Molina Galan's presentation at BIO 2009 was reported. The focus of this post is on the second part of his talk, where Mr. Molina Galan described the European Patent Office's role in fostering innovation. In his talk, Mr.…
-
By Sherri Oslick — Assembled by Chief Judge Paul R. Michel (at right) of the United States Court of Appeals for the Federal Circuit, a committee comprising litigators and judges from across the nation has prepared and published model jury instructions for patent infringement cases based on the experience of those both on the…
-
By Kevin E. Noonan — Early last week, the Journal of the American Medical Association published a study ("Interaction Between the Serotonin Transporter Gene (5-HTTLPR), Stressful Life Events, and Risk of Depression") by Neil Risch at the University of California, San Francisco and colleagues at the National Institutes of Mental Health, Johns Hopkins University,…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Sepracor Inc. et al. v. Synthon Pharmaceuticals, Inc. et al.5:09-cv-00264; filed June 17, 2009 in the Eastern District of North Carolina Infringement…
-
By Kevin E. Noonan — As reported last week by FierceBiotech, EvaluatePharma, a market forecasting firm specializing in the life sciences sector, released its prediction on the future of the pharmaceutical industry. According to EvaluatePharma, six of the top ten selling drugs by 2014 will be biologics. Today, half of the top ten best-selling…
-
By Ariadni Athanassiadis, Catherine Lemay, and Claire Palmer — In Canada, for subject matter to be patentable, it must be novel, inventive, and have utility. A patent will fail for lack of utility if it can be shown that "the invention will not work, either in the sense that it will not operate at all…
-
June 21-23, 2009 – IP Business Congress (Intellectual Asset Management magazine) – Chicago, IL June 22-27, 2009 – Innovation Week 2009 (U.S. Patent and Trademark Office) – Arlington, VA June 29-30 – Product and Pipeline Enhancement for Generics (Marcus Evans) – Washington, DC July 6, 2009 – Prior Art & Obviousness 2009: The PTO &…
-
The Law Bulletin Publishing Company will be holding its 4th Annual Corporate Intellectual Property Conference on July 15, 2009 in Chicago, IL. The conference will address the following topics: • Protecting and leveraging IP assets in a down economy;• Update on major case law affecting IP;• Licensing IP assets: Strategies for success;• Damages: Valuation and…
-
Marcus Evans has announced its 2nd Annual Product and Pipeline Enhancement for Generics conference on "Formulating a Concrete Plan for Sustainability in the Rapidly Changing Global Generic Pharmaceutical Market." The conference, to be held on June 29-30, 2009 in Washington, DC, will offer presentations on the following topics: • Ensuring the sustainability of the generics…
Patent Docs 